Medical Research
(H300)
IRS Verified
DX Registered
990 on File
CANCER RESEARCH INSTITUTE INC
Financial strength (30%)
65/100
Reliability (20%)
70/100
Effectiveness (25%)
85/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Cancer Research Institute supports and coordinates scientific and clinical efforts that will lead to the immunological control, and eventual cure of cancer.
Financial Overview — FY 2024
$24.0M
Total Revenue
$32.8M
Total Expenses
$66.8M
Net Assets
32
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
81.1%
Fundraising Efficiency
8547.6%
Operating Reserve
24.43x
Liability-to-Asset
50.0%
Revenue Diversification
84.1%
Executive Compensation
$2.2M
Compared with Peers
FY 2024
Compared with 98 similar organizations
(United States, Medical Research, $10M–$100M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
81.1% | 82.0% |
P10P90
|
Below median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
8.4% | 12.7% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
10.5% | 0.7% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
8547.6% | 693.4% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
24.4 mo | 14.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
50.0% | 21.3% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
84.1% | 90.8% |
P10P90
|
Above median |
|
Revenue growth
Year over year revenue growth
|
-25.8% | 9.6% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-14.9% | 7.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-37.0% | -1.2% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $24.0M | $32.8M | $66.8M | 81.1% | 32 |
| 2023 | $32.3M | $38.6M | $68.0M | 85.2% | 32 |
| 2022 | $33.7M | $31.3M | $66.7M | 82.0% | 36 |
| 2021 | $36.0M | $37.1M | N/A | — | 34 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.